Regulation and role of glycophagy in skeletal muscle energy metabolism

References

• Prats C, Graham TE, Shearer J. The dynamic life of the glycogen granule. J Biol Chem. 2018;293:7089–7098.
   PubMed Web of Science ®Google Scholar
• Jiang S, Wells CD, Roach PJ. Starch-binding domain-containing protein 1 (Stbd1) and glycogen metabolism: identification of the Atg8 family interacting motif (AIM) in Stbd1 required for interaction with GABARAPL1. Biochem Biophys Res Commun. 2011;413:420–425.
   PubMed Web of Science ®Google Scholar
• Goldfarb AH, Bruno JF, Buckenmeyer PJ. Intensity and duration of exercise effects on skeletal muscle cAMP, phosphorylase, and glycogen. J Appl Physiol. 1989;66:190–194.
   PubMed Web of Science ®Google Scholar
• Jensen TE, Richter EA. Regulation of glucose and glycogen metabolism during and after exercise. J Physiol. 2012;590:1069–1076.
   PubMed Web of Science ®Google Scholar
• Parolin ML, Spriet LL, Hultman E, et al. Regulation of glycogen phosphorylase and PDH during exercise in human skeletal muscle during hypoxia. Am J Physiol Endocrinol Metab. 2000;278:E522–34.
   PubMed Web of Science ®Google Scholar
• Sardiello M, Palmieri M, di Ronza A, et al. A gene network regulating lysosomal biogenesis and function. Science. 2009;325:473–477.
   PubMed Web of Science ®Google Scholar
• Kondomerkos DJ, Kalamidas SA, Kotoulas OB, et al. Glycogen autophagy in the liver and heart of newborn rats. The effects of glucagon, adrenalin or rapamycin. Histol Histopathol. 2005;20:689–696.
   PubMed Web of Science ®Google Scholar
• Yan B, Raben N, Plotz P. The human acid alpha-glucosidase gene is a novel target of the Notch-1/Hes-1 signaling pathway. J Biol Chem. 2002;277:29760–29764.
   PubMed Web of Science ®Google Scholar
• Yan B, Raben N, Plotz PH. Hes-1, a known transcriptional repressor, acts as a transcriptional activator for the human acid alpha-glucosidase gene in human fibroblast cells. Biochem Biophys Res Commun. 2002;291:582–587.
   PubMed Web of Science ®Google Scholar
• Dasouki M, Jawdat O, Almadhoun O, et al. Pompe disease: literature review and case series. Neurol Clin. 2014;32:751–76, ix.
   PubMed Web of Science ®Google Scholar
• Gusarov I, Pani B, Gautier L, et al. Glycogen controls Caenorhabditis elegans lifespan and resistance to oxidative stress. Nat Commun. 2017;8:15868.
   PubMed Web of Science ®Google Scholar
• Sarnat HB, Roth SI, Carroll JE, et al. Lipid storage myopathy in infantile Pompe’s disease. Arch Neurol. 1982;39:180–183.
   PubMedGoogle Scholar
• Selak MA, De Chadarevian JP, Melvin JJ, et al. Mitochondrial activity in Pompe’s disease. Pediatr Neurol. 2000;23:54–57.
   PubMed Web of Science ®Google Scholar
• Verity MA. Infantile Pompe’s disease, lipid storage, and partial carnitine deficiency. Muscle Nerve. 1991;14:435–440.
   PubMed Web of Science ®Google Scholar
• Douillard-Guilloux G, Raben N, Takikita S, et al. Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease. Hum Mol Genet. 2010;19:684–696.
   PubMed Web of Science ®Google Scholar
• Taylor KM, Meyers E, Phipps M, et al. Dysregulation of multiple facets of glycogen metabolism in a murine model of Pompe disease. PLoS One. 2013;8:e56181.
   PubMed Web of Science ®Google Scholar
• Lim JA, Li L, Shirihai OS, et al. Modulation of mTOR signaling as a strategy for the treatment of Pompe disease. EMBO Mol Med. 2017;9:353–370.
   PubMed Web of Science ®Google Scholar
• Shemesh A, Wang Y, Yang Y, et al. Suppression of mTORC1 activation in acid-alpha-glucosidase-deficient cells and mice is ameliorated by leucine supplementation. Am J Physiol Regul Integr Comp Physiol. 2014;307:R1251–9.
   PubMed Web of Science ®Google Scholar
• Wisselaar HA, Kroos MA, Hermans MM, et al. Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation. J Biol Chem. 1993;268:2223–2231.
   PubMed Web of Science ®Google Scholar
• Reuser AJ, Kroos M, Oude Elferink RP, et al. Defects in synthesis, phosphorylation, and maturation of acid alpha-glucosidase in glycogenosis type II. J Biol Chem. 1985;260:8336–8341.
   PubMed Web of Science ®Google Scholar
• Conley KE, Blei ML, Richards TL, et al. Activation of glycolysis in human muscle in vivo. Am J Physiol. 1997;273:C306–15.
   PubMed Web of Science ®Google Scholar
• Hingst JR, Bruhn L, Hansen MB, et al. Exercise-induced molecular mechanisms promoting glycogen supercompensation in human skeletal muscle. Mol Metab. 2018;16:24–34.
   PubMed Web of Science ®Google Scholar
• Dickinson JM, D’Lugos AC, Naymik MA, et al. Transcriptome response of human skeletal muscle to divergent exercise stimuli. J Appl Physiol. 2018;124:1529–1540.
   PubMed Web of Science ®Google Scholar
• Sandstrom ME, Abbate F, Andersson DC, et al. Insulin-independent glycogen supercompensation in isolated mouse skeletal muscle: role of phosphorylase inactivation. Pflugers Arch. 2004;448:533–538.
   PubMed Web of Science ®Google Scholar
• Abu-Remaileh M, Wyant GA, Kim C, et al. Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes. Science. 2017;358:807–813.
   PubMed Web of Science ®Google Scholar
• Cui W, Sathyanarayan A, Lopresti M, et al. Lipophagy-derived fatty acids undergo extracellular efflux via lysosomal exocytosis. Autophagy. 2020:7;1–16.
   PubMed Web of Science ®Google Scholar
• Yi H, Fredrickson KB, Das S, et al. Stbd1 is highly elevated in skeletal muscle of Pompe disease mice but suppression of its expression does not affect lysosomal glycogen accumulation. Mol Genet Metab. 2013;109:312–314.
   PubMed Web of Science ®Google Scholar
• Mansueto G, Armani A, Viscomi C, et al. Transcription factor EB controls metabolic flexibility during exercise. Cell Metab. 2017;25:182–196.
   PubMed Web of Science ®Google Scholar
• DeBosch BJ, Heitmeier MR, Mayer AL, et al. Trehalose inhibits solute carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic steatosis. Sci Signal. 2016;9:ra21.
   PubMed Web of Science ®Google Scholar
• Kitzmann M, Bonnieu A, Duret C, et al. Inhibition of Notch signaling induces myotube hypertrophy by recruiting a subpopulation of reserve cells. J Cell Physiol. 2006;208:538–548.
   PubMed Web of Science ®Google Scholar
• Hurtado-Bages S, Knobloch G, Ladurner AG, et al. The taming of PARP1 and its impact on NAD(+) metabolism. Mol Metab. 2020;38:100950.
   PubMed Web of Science ®Google Scholar
• Yang C, Ko B, Hensley CT, et al. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol Cell. 2014;56:414–424.
   PubMed Web of Science ®Google Scholar
• Hagglund MG, Sreedharan S, Nilsson VC, et al. Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons. J Biol Chem. 2011;286:20500–20511.
   PubMed Web of Science ®Google Scholar
• Ren Y, Shen HM. Critical role of AMPK in redox regulation under glucose starvation. Redox Biol. 2019;25:101154.
   PubMed Web of Science ®Google Scholar
• Chopra I, Li HF, Wang H, et al. Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle. Diabetologia. 2012;55:783–794.
   PubMed Web of Science ®Google Scholar
• Panzhinskiy E, Ren J, Nair S. Protein tyrosine phosphatase 1B and insulin resistance: role of endoplasmic reticulum stress/reactive oxygen species/nuclear factor kappa B axis. PLoS One. 2013;8:e77228.
   PubMed Web of Science ®Google Scholar
• Panzhinskiy E, Hua Y, Culver B, et al. Endoplasmic reticulum stress upregulates protein tyrosine phosphatase 1B and impairs glucose uptake in cultured myotubes. Diabetologia. 2013;56:598–607.
   PubMed Web of Science ®Google Scholar
• Tam CS, Covington JD, Bajpeyi S, et al. Weight gain reveals dramatic increases in skeletal muscle extracellular matrix remodeling. J Clin Endocrinol Metab. 2014;99:1749–1757.
   PubMed Web of Science ®Google Scholar
• Kang L, Ayala JE, Lee-Young RS, et al. Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin alpha2beta1 in mice. Diabetes. 2011;60:416–426.
   PubMed Web of Science ®Google Scholar
• Genini D, Carbone GM, Catapano CV. Multiple interactions between peroxisome proliferators-activated receptors and the ubiquitin-proteasome system and implicati]ons for cancer pathogenesis. PPAR Res. 2008;2008:195065.
   PubMed Web of Science ®Google Scholar
• Muoio DM, Way JM, Tanner CJ, et al. Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes. 2002;51:901–909.
   PubMed Web of Science ®Google Scholar
• Paukkeri EL, Leppanen T, Sareila O, et al. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages. Br J Pharmacol. 2007;152:1081–1091.
   PubMed Web of Science ®Google Scholar
• Pardridge WM, Casanello-Ertl D, Duducgian-Vartavarian L. Branched chain amino acid oxidation in cultured rat skeletal muscle cells. Selective inhibition by clofibric acid. J Clin Invest. 1980;66:88–93.
   PubMed Web of Science ®Google Scholar
• Acin-Perez R, Benador IY, Petcherski A, et al. A novel approach to measure mitochondrial respiration in frozen biological samples. EMBO J. 2020;39:e104073.
   PubMed Web of Science ®Google Scholar